Atlas Trials

Expanded Access Protocol (EAP) for Participants Receiving Idecabtagene Vicleucel That is Nonconforming for Commercial Release

Clinical trial NCT04771078 · AVAILABLE

Trial details

NCT number
NCT04771078
Sponsor
Celgene
Status
AVAILABLE
Study type
EXPANDED_ACCESS
Multiple Myeloma

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.